Stocklytics Platform
23andMe Holding Co.
ME60
$0.60arrow_drop_down21.81%-$0.16
High Growth
Penny Stock
ME60

$0.60

arrow_drop_down21.81%

Performance History

no data available for performance history chart

There's no data available for performance history chart

no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

no data available for Analyst Forecast

There's no data available for Analyst Forecast

Period: -

Predicted: -

Analyst Ratings

no data available for Analyst Ratings

There's no data available for Analyst Ratings

Last updated: -

Total: -

Correlated Companies

Price$86.65
Perf. (24h)arrow_drop_down0.69%-$0.60
Market Cap$699.55B
Price$962.00
Perf. (24h)arrow_drop_down0.52%-$5.08
Market Cap$429.07B
Price$172.15
Perf. (24h)arrow_drop_down0.23%-$0.39
Market Cap$404.22B
Price$72.85
Perf. (24h)arrow_drop_down0.35%-$0.26
Market Cap$314.93B

About 23andMe Holding Co. (ME)

23andMe Holding Co. (ME) is a company that specializes in genetic testing and analysis. They provide consumers with an opportunity to learn more about their DNA and gain insights into their health, wellness, and ancestry. The company was founded in 2006 and has since become a leader in the field of direct-to-consumer genetic testing. Their mission is to help individuals understand their genetic information and use it to make informed decisions about their health. As of the most recent data, 23andMe Holding Co. has a market capitalization of [market cap value] and a PEG ratio of [PEG ratio value].
In terms of the stock price history, 23andMe Holding Co. has experienced fluctuations over the past few years. However, it is important to note that past performance is not indicative of future results. Investors are advised to conduct their own research and analysis before making any investment decisions. In comparison to the industry, 23andMe Holding Co. has [positive/negative] performance. It is essential to consider various factors such as competition, market trends, and regulatory environment when evaluating the company's position within the industry.
Show more
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Ms. Anne Wojcicki
Headquarters
South San Francisco
Employees
758
Exchange
NASDAQ
add 23andMe Holding Co. to watchlist

Keep an eye on 23andMe Holding Co.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is 23andMe Holding Co. (ME) stock price performance year to date (YTD)?

As of the latest data, 23andMe Holding Co. (ME) has a year-to-date price change of -81.34%. Over the past month, the stock has experienced a price change of -58.76%. Over the last three months, the change has been -84%. Over the past six months, the figure is -92.2%.
help

What is 23andMe Holding Co.'s (ME) price per share?

The current price per share for 23andMe Holding Co. (ME) is $0.61. The stock has seen a price change of -$0.17 recently, indicating a -21.82% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for 23andMe Holding Co. (ME)?

For 23andMe Holding Co. (ME), the 52-week high is $5.31, which is 776.3% from the current price. The 52-week low is $0.27, the current price is 124.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is 23andMe Holding Co. (ME) a growth stock?

23andMe Holding Co. (ME) has shown an average price growth of -1.65% over the past three years. It has received a score of 77 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying 23andMe Holding Co. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

Is 23andMe Holding Co. (ME) a profitable company?

23andMe Holding Co. (ME) has a net income of -$666.7M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 45.25% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -41.87% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $99.38M. Operating income is noted at -$321.36M. Furthermore, the EBITDA is $68.24M.
help

What is the market capitalization of 23andMe Holding Co. (ME)?

23andMe Holding Co. (ME) has a market capitalization of $20.66M. The average daily trading volume is 0.8, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level